Schizophrenia: Who is at risk? Who is a case?

International Clinical Psychopharmacology

Volumn 21, Issue SUPPL. 2, 2006, Pages

  Verdoux, Hélène ^a,b,c   Cougnard, Audrey ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U657   (France)

^c CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Case definition; Prediction risk factors; Schizophrenia

Indexed keywords

ARTICLE; HEREDITY; HIGH RISK PATIENT; HUMAN; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ASPECT; SUBSTANCE ABUSE; FORECASTING; GENETICS; REVIEW; SOCIAL ENVIRONMENT;

FORECASTING; HUMANS; RISK FACTORS; SCHIZOPHRENIA; SOCIAL ENVIRONMENT;

EID: 33646709186     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Brown A, Cohen P, Greenwald S, Susser E (2000). Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry 157:438-443.
2. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. (2004). Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774-780.
3. Cannon M, Jones P, Murray R (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159:1080-1092.
4. Cannon M, Kendell R, Susser E, Jones P (2003). Prenatal and perinatal risk factors for schizophrenia. In: Murray R, Jones P, Susser E, van Os J, Cannon M, editors. The epidemiology of schizophrenia. Cambridge: Cambridge University Press.
5. Cougnard A, Salmi LR, Salamon R, Verdoux H (2005). A decision analysis model to assess the feasibility of the early detection of psychosis in the general population. Schizophr Res 74:27-36.
6. Geddes JR, Verdoux H, Takei N, Lawrie SM, Bovet P, Eagles JM, et al. (1999). Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr Bull 25:413-423.
7. Harrison PJ, Owen MJ (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361:417-419.
8. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68.
9. Malmerg A, Lewis G, David A, Allebeck P (1998). Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry 172:308-313.
10. Moynihan R, Heath I, Henry D, Gøtzsche P (2002). Selling sickness: the pharmaceutical industry and disease mongering. BMJ 324:886-891.
11. Murray R, O'Callaghan E, Castle D, Lewis S (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18:319-332.
12. Rose G (1992). The strategy of preventive medicine. Oxford: Oxford University Press.
13. van Os J, Takei N, Verdoux H, Delespaul P (1997). Early detection of schizophrenia. Br J Psychiatry 170:579.
14. Verdoux H (2004). Perinatal risk factors for schizophrenia: how specific are they? Curr Psychiatry Rep 6:162-167.
15. Verdoux H, Cougnard A (2003). The early detection and treatment controversy in schizophrenia research. Curr Opin Psychiatry 16:175-179.
16. Verdoux H, van Os J (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res 54:59-65.
17. Woods S, Miller T, Davidson L, Hawkins K, Sernyak M, McGlashan T (2001). Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients. Schizophr Res 52:21-27.